Trial Profile
Clinical Outcomes Among a National Veterans Affairs Methicillin Resistant Staphylococcus Aureus (MRSA) Pneumonia Cohort Treated With Linezolid Or Vancomycin
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 20 Mar 2014
Price :
$35
*
At a glance
- Drugs Linezolid (Primary) ; Vancomycin
- Indications Pneumonia; Staphylococcal infections
- Focus Therapeutic Use
- Sponsors Pfizer
- 18 Apr 2013 Planned End Date changed from 1 Mar 2013 to 1 Apr 2013 as reported by ClinicalTrials.gov.
- 05 Apr 2013 New trial record
- 01 Apr 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.